Clinical trial
Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer
NCT06307938 is registered in ClinicalTrials.gov with Helse Nord-Trøndelag HF as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer
- Lead sponsor
- Helse Nord-Trøndelag HF
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 10, 2025
- Completion date
- May 31, 2028
- Enrollment
- 3,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal adenoma, colorectal cancer